{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:10:25Z","timestamp":1788772225632,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015569","name":"Canadian Consortium on Neurodegeneration in Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.genhosppsych.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:52:48Z","timestamp":1785455568000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The Association Between Serum Neurofilament Light Chain and Inflammatory Markers in Psychiatric Disorders"],"prefix":"10.1016","volume":"102","author":[{"given":"Patricia","family":"Humer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri Lee","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Light","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdie","family":"Soltaninejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.genhosppsych.2026.07.012_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejpn.2023.05.003","article-title":"Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases","volume":"45","author":"Geis","year":"2023","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.07.012_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2021-000143","article-title":"Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis","volume":"3","author":"Alagaratnam","year":"2021","journal-title":"BMJ Neurol Open"},{"issue":"18","key":"10.1016\/j.genhosppsych.2026.07.012_bb0020","doi-asserted-by":"crossref","first-page":"e2296","DOI":"10.1212\/WNL.0000000000011848","article-title":"Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration","volume":"96","author":"Rojas","year":"2021","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.genhosppsych.2026.07.012_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jagp.2024.03.008","article-title":"Clinical accuracy of serum neurofilament light to differentiate frontotemporal dementia from primary psychiatric disorders is age-dependent","volume":"32","author":"Light","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpsychires.2021.05.072","article-title":"Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum","volume":"140","author":"Bavato","year":"2021","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0035","doi-asserted-by":"crossref","DOI":"10.64898\/2026.04.08.26350391","article-title":"Plasma neurofilament light chain and glial fibrillary acidic protein in psychiatric disorders: a large-scale normative modeling study","author":"Jacobsen","year":"2026","journal-title":"Psychiatry Clin Psychol"},{"issue":"7","key":"10.1016\/j.genhosppsych.2026.07.012_bb0040","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1007\/s12035-023-03327-6","article-title":"A longitudinal investigation of blood neurofilament light chain levels in chronic cocaine users","volume":"60","author":"Bavato","year":"2023","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111189","article-title":"Plasma neurofilament light chain levels are associated with delirium tremens in patients with alcohol use disorder","volume":"136","author":"Hou","year":"2025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0050","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpsychires.2023.01.009","article-title":"Comorbidity of ketamine dependence with major depressive disorder increases the vulnerability to neuroaxonal pathology","volume":"158","author":"Huang","year":"2023","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jad.2023.06.028","article-title":"Serum glial fibrillary acidic protein and neurofilament light chain in treatment-na\u00efve patients with unipolar depression","volume":"338","author":"Hviid","year":"2023","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.07.012_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-12287-1","article-title":"Plasma levels of S100B and neurofilament light chain protein in stress-related mental disorders","volume":"12","author":"Wallensten","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0065","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jad.2021.10.074","article-title":"Alzheimer\u2019s disease related biomarkers in bipolar disorder \u2013 a longitudinal one-year case-control study","volume":"297","author":"Knorr","year":"2022","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2019.03.019","article-title":"Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia","volume":"113","author":"Al Shweiki","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0075","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jad.2024.07.146","article-title":"Serum neurofilament light chain, markers of systemic inflammation and clinically relevant depressive symptoms in US adults","volume":"363","author":"Guo","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172981","article-title":"Neuroinflammation in psychiatric disorders: an introductory primer","volume":"196","author":"Dunn","year":"2020","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"10.1016\/j.genhosppsych.2026.07.012_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fpsyt.2017.00221","article-title":"Interleukin-6 in schizophrenia-is there a therapeutic relevance?","volume":"8","author":"Borovcanin","year":"2017","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-021-03569-5","article-title":"Relationship between TNF-\u03b1 levels and psychiatric symptoms in first-episode drug-na\u00efve patients with schizophrenia before and after risperidone treatment and in chronic patients","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2026.07.012_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2026.07.012_bb0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.24869\/psyd.2017.407","article-title":"A systematic review of tumor necrosis factor-\u03b1 in post-traumatic stress disorder: evidence from human and animal studies","volume":"29","author":"Hussein","year":"2017","journal-title":"Psychiatr Danub."},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.07.012_bb0110","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1038\/s41598-024-59530-5","article-title":"Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment","volume":"14","author":"Jing","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115718","article-title":"The signature biobank: a longitudinal biopsychosocial repository of psychiatric emergency patients","volume":"332","author":"Kerr","year":"2024","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0120","doi-asserted-by":"crossref","unstructured":"Zarglayoun H, Jones SL, Light V, et al. Serum neurofilament light as a neuropsychiatric disorder screening test in psychiatric emergency settings. J Neuropsychiatry Clin Neurosci. 2025. Published online October 16, appi.neuropsych.20240228. doi:https:\/\/doi.org\/10.1176\/appi.neuropsych.20240228.","DOI":"10.1176\/appi.neuropsych.20240228"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0125","author":"Centre de Recherche IUSMM"},{"issue":"11","key":"10.1016\/j.genhosppsych.2026.07.012_bb0130","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.chiabu.2008.05.003","article-title":"Measurement of victimization in adolescence: development and validation of the Childhood Experiences of Violence Questionnaire","volume":"32","author":"Walsh","year":"2008","journal-title":"Child Abuse Negl"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0135","series-title":"Audit. Alcohol Use Disord Identif Test AUDIT Guidel Use Prim Care","author":"Babor","year":"2001"},{"issue":"4","key":"10.1016\/j.genhosppsych.2026.07.012_bb0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0306-4603(82)90005-3","article-title":"The drug abuse screening test","volume":"7","author":"Skinner","year":"1982","journal-title":"Addict Behav"},{"issue":"5","key":"10.1016\/j.genhosppsych.2026.07.012_bb0145","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/brain\/awh425","article-title":"Atypical sleep architecture and the autism phenotype","volume":"128","author":"Limoges","year":"2005","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.genhosppsych.2026.07.012_bb0150","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.genhosppsych.2026.07.012_bb0155","first-page":"559","article-title":"Adaptation canadienne-fran\u00e7aise de la forme r\u00e9vis\u00e9e du State\u2013Trait Anxiety Inventory de Spielberger","volume":"25","author":"Gauthier","year":"1993","journal-title":"Can J Behav Sci Rev Can Sci Comport"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.07.012_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","article-title":"The development of a six-item short-form of the state scale of the Spielberger State\u2014Trait Anxiety Inventory (STAI)","volume":"31","author":"Marteau","year":"1992","journal-title":"Br J Clin Psychol"},{"issue":"101","key":"10.1016\/j.genhosppsych.2026.07.012_bb0165","article-title":"A neurologist\u2019s perspective on serum neurofilament light in the memory clinic: a prospective implementation study","volume":"13","author":"Willemse","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0170","author":"Quanterix Corporation"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0175","series-title":"Quantikine HS ELISA Human IL-6 Immunoassay Catalog Number HS600B SS600B PHS600B","author":"R&D Systems","year":"2017"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0180","series-title":"Quantikine HS ELISA Human TNF-\u03b1 Immunoassay Catalog Number HSTA00D SSTA00D PHSTA00D","author":"R&D Systems","year":"2013"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0185","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.07.012_bb0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","article-title":"User\u2019s guide to correlation coefficients","volume":"18","author":"Akoglu","year":"2018","journal-title":"Turk J Emerg Med"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.edurev.2010.12.001","article-title":"Eta squared and partial eta squared as measures of effect size in educational research","volume":"6","author":"Richardson","year":"2011","journal-title":"Educ Res Rev"},{"issue":"12","key":"10.1016\/j.genhosppsych.2026.07.012_bb0200","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.07.012_bb0205","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/biomedinformatics2030028","article-title":"Application of standardized regression coefficient in meta-analysis","volume":"2","author":"Nieminen","year":"2022","journal-title":"BioMedInformatics"},{"issue":"11","key":"10.1016\/j.genhosppsych.2026.07.012_bb0210","article-title":"Similarities between depression and neurodegenerative diseases: pathophysiology, challenges in diagnosis and treatment options","volume":"12","author":"Hussain","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2019.04.002","article-title":"Depression in neurodegenerative diseases: common mechanisms and current treatment options","volume":"102","author":"Galts","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.genhosppsych.2026.07.012_bb0220","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.5213\/inj.1632604.302","article-title":"Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders","volume":"20","author":"Hong","year":"2016","journal-title":"Int Neurourol J"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.07.012_bb0225","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/s41467-022-31873-5","article-title":"Shared mechanisms across the major psychiatric and neurodegenerative diseases","volume":"13","author":"Wingo","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.genhosppsych.2026.07.012_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115382","article-title":"Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation","volume":"44","author":"Kahn","year":"2025","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.genhosppsych.2026.07.012_bb0235","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"13","author":"Sproston","year":"2018","journal-title":"Front Immunol"},{"issue":"47","key":"10.1016\/j.genhosppsych.2026.07.012_bb0240","first-page":"48487","article-title":"C-reactive protein","volume":"279","author":"Black","year":"2004","journal-title":"Mini Rev"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0245","article-title":"C-reactive protein in major depressive disorder: Promise and challenge","volume":"10","author":"Halaris","year":"2022","journal-title":"J Affect Disord Rep"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0250","first-page":"12","article-title":"Monomeric C-reactive protein localized in the cerebral tissue of damaged vascular brain regions is associated with neuro-inflammation and neurodegeneration-an immunohistochemical study","author":"Al-Baradie","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0255","series-title":"Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders","first-page":"135","article-title":"C-reactive protein (CRP): a potent inflammation biomarker in psychiatric disorders","author":"Orsolini","year":"2023"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.07.012_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30487-6","article-title":"IL-1\u03b2, IL-6, TNF- \u03b1 and CRP in elderly patients with depression or Alzheimer\u2019s disease: systematic review and meta-analysis","volume":"8","author":"Ng","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.genhosppsych.2026.07.012_bb0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/life15010047","article-title":"The role of IL-6 and TNF-alpha biomarkers in predicting disability outcomes in acute ischemic stroke patients","volume":"15","author":"B\u0103cil\u0103","year":"2025","journal-title":"Life"},{"issue":"4","key":"10.1016\/j.genhosppsych.2026.07.012_bb0270","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41380-023-01976-6","article-title":"The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis","volume":"28","author":"Gigase","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2026.07.012_bb0275","article-title":"Serum levels of neurofilament light-chain (NfL), a biomarker of axonal and synaptic damage, predict 5-year outcome in acutely ill schizophrenia patients","volume":"12","author":"Popovic","year":"2023","journal-title":"J Affect Disord Rep"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834326001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834326001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:40:35Z","timestamp":1788770435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834326001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"alternative-id":["S0163834326001635"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2026.07.012","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association Between Serum Neurofilament Light Chain and Inflammatory Markers in Psychiatric Disorders","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}